The Evaluation of Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of JPI-289 in Healthy Male Volunteers

NCT02396069 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Stroke

Interventions

DRUG: JPI-289
DRUG: Placebo

Sponsor

Jeil Pharmaceutical Co., Ltd.